This paper summarizes the data from updated international protocols and guidelines for
diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). The invasive and non …

В статье суммированы данные обновленных международных протоколов и
рекомендаций по диагностике транстиретиновой амилоидной кардиомиопатии (ATTR …

Previous studies suggest worse outcomes in patients with variant transthyretin cardiac
amyloidosis (ATTR-CA) because of valine-to-isoleucine substitution at Position 122 …

Background Diagnosis of hereditary amyloid transthyretin (hATTR) amyloidosis with
cardiomyopathy is frequently delayed, in large part because of symptom overlap with other …

Abstract Background Both hereditary transthyretin (ATTRv) amyloidosis and wildtype
transthyretin (ATTRwt) amyloidosis can be associated with neurological diseases such as …

Aim: The six-minute walk test (6MWT) is a common measure of functional capacity in
patients with heart failure (HF). Primary clinical study end points in cardiomyopathy (CM) …

Background The prognostic value of cardiopulmonary exercise testing (CPET) in patients
with wild-type transthyretin cardiac amyloidosis treated with tafamidis is unknown. Methods …

The term “amyloidosis” encompasses a heterogeneous group of acquired or hereditary,
localized or systemic disorders, caused by the extracellular deposition of amyloid fibrils …

Aim and methods We conducted a retrospective observational study of the ATTRv
heterozygous mutation frequency, phenotype, and all-cause mortality at two cardiac …

Objective This study aims to delineate the clinical profiles of the hereditary transthyretin
amyloid polyneuropathy (ATTRv-PN) patients with A97S variant from southern China and …